ERBB2 and neoplasm: The HER2-CD3-Fc bsAb in the culture significantly enhanced T cell secretion of IFN-λ, TNF-α, and granzyme B in response to NCI-H460 tumor cells in a dose-dependent manner (Figure 3A–C).